IDStewardship

  • Home
  • Articles
  • LEARN ANTIBIOTICS
  • Study Guide
  • Resources
  • Q&A
  • #ASPchat
  • Contributors
  • About

Paul Ambrose, Pharm.D., FIDSA

Dr. Paul Ambrose (Pharm.D., FIDSA) serves as President of the Institute for Clinical Pharmacodynamics (ICPD). He has held academic appointments at the University of Oxford and the University at Buffalo. Primarily, Dr. Ambrose’s area of expertise is the application of pharmacokinetic-pharmacodynamic PK-PD principles within infectious diseases.

ARTICLES

Pharmacokinetics And Pharmacodynamics For Antibiotics: Back To Basics

The PK-PD Compass, An Antimicrobial Steward’s New Best Friend

LEARN ANTIBIOTICS

Paperback Book

STEWARD PINS

Subscribe

Sign up for the monthly newsletter!

We will never spam you. We want you to like us. By clicking the Subscribe button, you accept the Terms of Service and Privacy Policy.

Categories

  • COVID-19
  • Healthcare At Large
  • Infectious Diseases & Antimicrobial Stewardship
  • Pharmacy News
  • Reality Check
  • Residency & Training
  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • Tumblr
  • Twitter
  • YouTube

Recent Posts

  • Antimicrobial Stewardship in Turkey – A Clinical Pharmacist’s Perspective
  • The World Health Organization’s Use of Firstline: Pushing Antimicrobial Stewardship Forward
  • Spotlight On The Infectious Diseases Podcast Over 15 Years Old That Just Added New Mobile Streaming Options
  • The Cross-Roads Of Artificial Intelligence & Infectious Diseases Education: Witty Insights From ChatGPT
  • How Pharmacists Can Use Artificial Intelligence To Advance Their Practice: Insights From ChatGPT

COVID-19

Musical Chairs & The ABCs of SARS-CoV-2 Monoclonal Antibodies

Musical Chairs & The ABCs of SARS-CoV-2 Monoclonal Antibodies

A Comparison Of Paxlovid Versus Molnupiravir: The First Oral COVID Antivirals

A Comparison Of Paxlovid Versus Molnupiravir: The First Oral COVID Antivirals

Five Things For Pharmacists To Know About The Omicron Variant

Five Things For Pharmacists To Know About The Omicron Variant

Molnupiravir – The New COVID Antiviral Named After Thor’s Hammer

Molnupiravir – The New COVID Antiviral Named After Thor’s Hammer

Tags

antibiotic Antibiotics antimicrobial stewardship bcps beta-lactam cancer Chemotherapy Clinical Controversies clinical pharmacist clinical pharmacy community pharmacist Critical Care emergency medicine Emoji Game fellowship figure1 Hepatitis C hospital pharmacist hospital pharmacy Infectious Disease infectious diseases Lifestyle MRSA NAPLEX Natural Disaster oncology pharmacist one-on-one penicillin allergy PGY2 pharmacy fellowship Pharmacy Job pharmacy practice pharmacy residency pharmacy school pharmacy student Pharmacy technician PK-PD Compass Predatory Journals Rapid Diagnostic Testing residency social media student pharmacist study table transplant Zika

Penicillin Allergy Assessment Certificate Program

Recent

  • Antimicrobial Stewardship in Turkey – A Clinical Pharmacist’s Perspective
  • The World Health Organization’s Use of Firstline: Pushing Antimicrobial Stewardship Forward
  • Spotlight On The Infectious Diseases Podcast Over 15 Years Old That Just Added New Mobile Streaming Options
  • The Cross-Roads Of Artificial Intelligence & Infectious Diseases Education: Witty Insights From ChatGPT
  • How Pharmacists Can Use Artificial Intelligence To Advance Their Practice: Insights From ChatGPT

Search

Copyright 2016-2020 By Charlie Rose, LLC © · IDStewardship.com · Copyright · Privacy Policy · Terms · Contact